LBA89 A randomized multicentered phase III study to evaluate apatinib in subjects with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer
Y-S. Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), S. Qin(Nanjing General Hospital of Nanjing Military Command), ZY Li(Xuzhou Medical College), Han‐Kwang Yang(Henan Cancer Hospital), Wei Fu(Guilin Medical University), SH Li, W-X. Chen(Fujian Provincial Hospital), Gao Zr(Union Hospital), W-B. Miao(Fujian Medical University), H-Q. Xu(Anhui Medical University), Qiang Zhang(Nanchang University), X-M. Zhao(Hebei Medical University), J-D. Bao, Lifeng Li(Zhejiang Cancer Hospital), Yongcheng Ren(Shanxi Provincial Cancer Hospital), CH Lin(Jilin University), S-H. Jing(Hebei Medical University), Q-J. Ma(Union Hospital), Jintai Liang(Peking University), Guan-Ju Chen(Jilin University)
Cited by 3
Abstract
Related Papers
No related papers found
Powered by citation graph analysis